{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:18:18Z","timestamp":1789996698108,"version":"4.0.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,23]]},"DOI":"10.7759\/cureus.38019","type":"journal-article","created":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T11:46:30Z","timestamp":1682250390000},"source":"Crossref","is-referenced-by-count":10,"title":["Role of Oral Retinoids in Treatment of Acne Vulgaris With a Bioinformatics-Based Perspective of Personalized Medicine"],"prefix":"10.7759","author":[{"given":"Renee","family":"Scott-Emuakpor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiranmayi","family":"Vuthaluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhijit","family":"Nagre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inshal","family":"Jawed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyansh A","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmandeep K","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"The modern age of acne therapy: a review of current treatment options","volume":"68","author":"Bershad SV","year":"2001","unstructured":"Bershad SV. The modern age of acne therapy: a review of current treatment options. Mt Sinai J Med. 2001, 68:279-286.","journal-title":"Mt Sinai J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2009.03.012","article-title":"The role of Propionibacterium acnes in acne pathogenesis: facts and controversies","volume":"28","author":"Dessinioti C","year":"2010","unstructured":"Dessinioti C, Katsambas AD. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies. Clin Dermatol. 2010, 28:2-7. 10.1016\/j.clindermatol.2009.03.012","journal-title":"Clin Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2004.03.009","article-title":"Acne: topical treatment","volume":"22","author":"Krautheim A","year":"2004","unstructured":"Krautheim A, Gollnick HP. Acne: topical treatment. Clin Dermatol. 2004, 22:398-407. 10.1016\/j.clindermatol.2004.03.009","journal-title":"Clin Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13765","article-title":"Psychodermatology of acne: Psychological aspects and effects of acne vulgaris","volume":"20","author":"Stamu-O'Brien C","year":"2021","unstructured":"Stamu-O'Brien C, Jafferany M, Carniciu S, Abdelmaksoud A. Psychodermatology of acne: Psychological aspects and effects of acne vulgaris. J Cosmet Dermatol. 2021, 20:1080-1083. 10.1111\/jocd.13765","journal-title":"J Cosmet Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.02.040","article-title":"Acne vulgaris and risk of depression and anxiety: a meta-analytic review","volume":"83","author":"Samuels DV","year":"2020","unstructured":"Samuels DV, Rosenthal R, Lin R, Chaudhari S, Natsuaki MN. Acne vulgaris and risk of depression and anxiety: a meta-analytic review. J Am Acad Dermatol. 2020, 83:532-541. 10.1016\/j.jaad.2020.02.040","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250155","article-title":"Quality of life in Montenegrin pupils with acne","volume":"16","author":"\u0110urovi\u0107 MR","year":"2021","unstructured":"\u0110urovi\u0107 MR, \u0110urovi\u0107 M, Jankovi\u0107 J, Jankovi\u0107 S. Quality of life in Montenegrin pupils with acne. PLoS One. 2021, 16:e0250155. 10.1371\/journal.pone.0250155","journal-title":"PLoS One"},{"key":"ref7","article-title":"Skin care and incidence of skin disease in adolescence","volume":"7","author":"Strauss JS","year":"1982","unstructured":"Strauss JS. Skin care and incidence of skin disease in adolescence. Curr Med Res Opin. 1982, 7:33-45.","journal-title":"Curr Med Res Opin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1946.tb11329.x","article-title":"The incidence of clinical acne in men","volume":"58","author":"Forbes HA","year":"1946","unstructured":"Forbes HA. The incidence of clinical acne in men. Br J Dermatol Syph. 1946, 58:298-300. 10.1111\/j.1365-2133.1946.tb11329.x","journal-title":"Br J Dermatol Syph"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos T","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, et al.. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012, 380:2163-2196. 10.1016\/S0140-6736(12)61729-2","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.1997.tb01126.x","article-title":"Descriptive epidemiology of acne vulgaris in the community","volume":"38","author":"Stathakis V","year":"1997","unstructured":"Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J Dermatol. 1997, 38:115-123. 10.1111\/j.1440-0960.1997.tb01126.x","journal-title":"Australas J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.2009.03340.x","article-title":"Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong","volume":"35","author":"Law MP","year":"2010","unstructured":"Law MP, Chuh AA, Lee A, Molinari N. Acne prevalence and beyond: acne disability and its predictive factors among Chinese late adolescents in Hong Kong. Clin Exp Dermatol. 2010, 35:16-21. 10.1111\/j.1365-2230.2009.03340.x","journal-title":"Clin Exp Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2009.03922.x","article-title":"Acne vulgaris in Nigerian adolescents -- prevalence, severity, beliefs, perceptions, and practices","volume":"48","author":"Yahya H","year":"2009","unstructured":"Yahya H. Acne vulgaris in Nigerian adolescents -- prevalence, severity, beliefs, perceptions, and practices. Int J Dermatol. 2009, 48:498-505. 10.1111\/j.1365-4632.2009.03922.x","journal-title":"Int J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6682.1217","article-title":"Acne in schoolchildren: no longer a concern for dermatologists","volume":"298","author":"Rademaker M","year":"1989","unstructured":"Rademaker M, Garioch JJ, Simpson NB. Acne in schoolchildren: no longer a concern for dermatologists. BMJ. 1989, 298:1217. 10.1136\/bmj.298.6682.1217","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000017838","article-title":"A review of infantile and pediatric acne","volume":"196","author":"Lucky AW","year":"1998","unstructured":"Lucky AW. A review of infantile and pediatric acne. Dermatology. 1998, 196:95-97. 10.1159\/000017838","journal-title":"Dermatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03590.x","article-title":"The epidemiology of adolescent acne in North East China","volume":"24","author":"Wei B","year":"2010","unstructured":"Wei B, Pang Y, Zhu H, et al.. The epidemiology of adolescent acne in North East China. J Eur Acad Dermatol Venereol. 2010, 24:953-957. 10.1111\/j.1468-3083.2010.03590.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12541101","article-title":"Prevalence, morbidity, and cost of dermatological diseases","volume":"73","year":"1979","unstructured":"Prevalence, morbidity, and cost of dermatological diseases. J Invest Dermatol. 1979, 73.395-401. 10.1111\/1523-1747.ep12541101","journal-title":"J Invest Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(98)70442-6","article-title":"Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris","volume":"39","author":"White GM","year":"1998","unstructured":"White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998, 39:34-37. 10.1016\/s0190-9622(98)70442-6","journal-title":"J Am Acad Dermatol"},{"key":"ref18","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.1991.01680020078009","article-title":"Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age","volume":"127","author":"Lucky AW","year":"1991","unstructured":"Lucky AW, Biro FM, Huster GA, Morrison JA, Elder N. Acne vulgaris in early adolescent boys. Correlations with pubertal maturation and age. Arch Dermatol. 1991, 127:210-216.","journal-title":"Arch Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3476(97)70307-x","article-title":"Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study","volume":"130","author":"Lucky AW","year":"1997","unstructured":"Lucky AW, Biro FM, Simbartl LA, Morrison JA, Sorg NW. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr. 1997, 130:30-39. 10.1016\/s0022-3476(97)70307-x","journal-title":"J Pediatr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/jech.30.2.107","article-title":"Skin disease in Lambeth. A community study of prevalence and use of medical care","volume":"30","author":"Rea JN","year":"1976","unstructured":"Rea JN, Newhouse ML, Halil T. Skin disease in Lambeth. A community study of prevalence and use of medical care. J Epidemiol Commun Health. 1976, 30:107-114. 10.1136\/jech.30.2.107","journal-title":"J Epidemiol Commun Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.12.1614","article-title":"French people and skin diseases: results of a survey using a representative sample","volume":"139","author":"Wolkenstein P","year":"2003","unstructured":"Wolkenstein P, Grob JJ, Bastuji-Garin S, Ruszczynski S, Roujeau JC, Revuz J. French people and skin diseases: results of a survey using a representative sample. Arch Dermatol. 2003, 139:1614-1619. 10.1001\/archderm.139.12.1614","journal-title":"Arch Dermatol"},{"key":"ref22","article-title":"Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974","author":"Johnson MT","year":"1978","unstructured":"Johnson MT, Roberts J. Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974. Vital Health Stat 11. 1978, i-v, 1-72.","journal-title":"Vital Health Stat 11"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60321-8","article-title":"Acne vulgaris","volume":"379","author":"Williams HC","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S. Acne vulgaris. The Lancet. 2012, 379:361-372. 10.1016\/S0140-6736(11)60321-8","journal-title":"The Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2010.04.002","article-title":"Acne epidemiology and pathophysiology","volume":"29","author":"Friedlander SF","year":"2010","unstructured":"Friedlander SF, Eichenfield LF, Fowler JF Jr, Fried RG, Levy ML, Webster GF. Acne epidemiology and pathophysiology. Semin Cutan Med Surg. 2010, 29:2-4. 10.1016\/j.sder.2010.04.002","journal-title":"Semin Cutan Med Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2011.07.003","article-title":"Acne life cycle: the spectrum of pediatric disease","volume":"30","author":"Mancini AJ","year":"2011","unstructured":"Mancini AJ, Baldwin HE, Eichenfield LF, Friedlander SF, Yan AC. Acne life cycle: the spectrum of pediatric disease. Semin Cutan Med Surg. 2011, 30:2-5. 10.1016\/j.sder.2011.07.003","journal-title":"Semin Cutan Med Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1478","article-title":"Recent changes in pubertal timing in healthy Danish boys: associations with body mass index","volume":"95","author":"S\u00f8rensen K","year":"2010","unstructured":"S\u00f8rensen K, Aksglaede L, Petersen JH, Juul A. Recent changes in pubertal timing in healthy Danish boys: associations with body mass index. J Clin Endocrinol Metab. 2010, 95:263-270. 10.1210\/jc.2009-1478","journal-title":"J Clin Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809050-00001","article-title":"Can we define acne as a chronic disease? If so, how and when?","volume":"9","author":"Gollnick HP","year":"2008","unstructured":"Gollnick HP, Finlay AY, Shear N. Can we define acne as a chronic disease? If so, how and when?. Am J Clin Dermatol. 2008, 9:279-284. 10.2165\/00128071-200809050-00001","journal-title":"Am J Clin Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00357.x","article-title":"An epidemiological study of acne in female adults: results of a survey conducted in France","volume":"15","author":"Poli F","year":"2001","unstructured":"Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol. 2001, 15:541-545. 10.1046\/j.1468-3083.2001.00357.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.06.045","article-title":"The prevalence of acne in adults 20 years and older","volume":"58","author":"Collier CN","year":"2008","unstructured":"Collier CN, Harper JC, Cafardi JA, Cantrell WC, Wang W, Foster KW, Elewski BE. The prevalence of acne in adults 20 years and older. J Am Acad Dermatol. 2008, 58:56-59. 10.1016\/j.jaad.2007.06.045","journal-title":"J Am Acad Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.01.019","article-title":"New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group","volume":"60","author":"Thiboutot D","year":"2009","unstructured":"Thiboutot D, Gollnick H, Bettoli V, et al.. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009, 60:1-50. 10.1016\/j.jaad.2009.01.019","journal-title":"J Am Acad Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04290.x","article-title":"Epidemiology of acne in the general population: the risk of smoking","volume":"145","author":"Sch\u00e4fer T","year":"2001","unstructured":"Sch\u00e4fer T, Nienhaus A, Vieluf D, Berger J, Ring J. Epidemiology of acne in the general population: the risk of smoking. Br J Dermatol. 2001, 145:100-104. 10.1046\/j.1365-2133.2001.04290.x","journal-title":"Br J Dermatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.6171.1109","article-title":"Prevalence of facial acne vulgaris in late adolescence and in adults","volume":"1","author":"Cunliffe WJ","year":"1979","unstructured":"Cunliffe WJ, Gould DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J. 1979, 1:1109. 10.1136\/bmj.1.6171.1109","journal-title":"Br Med J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2018.04.015","article-title":"Dairy intake and acne development: a meta-analysis of observational studies","volume":"38","author":"Aghasi M","year":"2019","unstructured":"Aghasi M, Golzarand M, Shab-Bidar S, Aminianfar A, Omidian M, Taheri F. Dairy intake and acne development: a meta-analysis of observational studies. Clin Nutr. 2019, 38:1067-1075. 10.1016\/j.clnu.2018.04.015","journal-title":"Clin Nutr"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/1743-7075-8-41","article-title":"Over-stimulation of insulin\/IGF-1 signaling by Western diet may promote diseases of civilization: lessons learnt from Laron syndrome","volume":"8","author":"Melnik BC","year":"2011","unstructured":"Melnik BC, John SM, Schmitz G. Over-stimulation of insulin\/IGF-1 signaling by Western diet may promote diseases of civilization: lessons learnt from Laron syndrome. Nutr Metab (Lond). 2011, 8:41. 10.1186\/1743-7075-8-41","journal-title":"Nutr Metab (Lond)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200700307","article-title":"A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial","volume":"52","author":"Smith R","year":"2008","unstructured":"Smith R, Mann N, M\u00e4kel\u00e4inen H, Roper J, Braue A, Varigos G. A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol Nutr Food Res. 2008, 52:718-726. 10.1002\/mnfr.200700307","journal-title":"Mol Nutr Food Res"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.01.046","article-title":"The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial","volume":"57","author":"Smith RN","year":"2007","unstructured":"Smith RN, Mann NJ, Braue A, M\u00e4kel\u00e4inen H, Varigos GA. The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial. J Am Acad Dermatol. 2007, 57:247-256. 10.1016\/j.jaad.2007.01.046","journal-title":"J Am Acad Dermatol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-017-1795-3","article-title":"Skin barrier and microbiome in acne","volume":"310","author":"Rocha MA","year":"2018","unstructured":"Rocha MA, Bagatin E. Skin barrier and microbiome in acne. Arch Dermatol Res. 2018, 310:181-185. 10.1007\/s00403-017-1795-3","journal-title":"Arch Dermatol Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12224","article-title":"Propionibacterium acnes: an update on its role in the pathogenesis of acne","volume":"28","author":"Beylot C","year":"2014","unstructured":"Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, Dreno B. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2014, 28:271-278. 10.1111\/jdv.12224","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14409","article-title":"Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet","volume":"174","author":"Agamia NF","year":"2016","unstructured":"Agamia NF, Abdallah DM, Sorour O, Mourad B, Younan DN. Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet. Br J Dermatol. 2016, 174:1299-1307. 10.1111\/bjd.14409","journal-title":"Br J Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12885","article-title":"Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin","volume":"25","author":"Monfrecola G","year":"2016","unstructured":"Monfrecola G, Lembo S, Caiazzo G, De Vita V, Di Caprio R, Balato A, Fabbrocini G. Mechanistic target of rapamycin (mTOR) expression is increased in acne patients' skin. Exp Dermatol. 2016, 25:153-155. 10.1111\/exd.12885","journal-title":"Exp Dermatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2174\/1389200216666150812124801","article-title":"Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris","volume":"16","author":"Liu PF","year":"2015","unstructured":"Liu PF, Hsieh YD, Lin YC, Two A, Shu CW, Huang CM. Propionibacterium acnes in the pathogenesis and immunotherapy of acne vulgaris. Curr Drug Metab. 2015, 16:245-254. 10.2174\/1389200216666150812124801","journal-title":"Curr Drug Metab"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/srep39491","article-title":"The balance of metagenomic elements shapes the skin microbiome in acne and health","volume":"6","author":"Barnard E","year":"2016","unstructured":"Barnard E, Shi B, Kang D, Craft N, Li H. The balance of metagenomic elements shapes the skin microbiome in acne and health. Sci Rep. 2016, 6:39491. 10.1038\/srep39491","journal-title":"Sci Rep"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.21","article-title":"Propionibacterium acnes strain populations in the human skin microbiome associated with acne","volume":"133","author":"Fitz-Gibbon S","year":"2013","unstructured":"Fitz-Gibbon S, Tomida S, Chiu BH, et al.. Propionibacterium acnes strain populations in the human skin microbiome associated with acne. J Invest Dermatol. 2013, 133:2152-2160. 10.1038\/jid.2013.21","journal-title":"J Invest Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-019-01908-x","article-title":"From pathogenesis of acne vulgaris to anti-acne agents","volume":"311","author":"Cong TX","year":"2019","unstructured":"Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to anti-acne agents. Arch Dermatol Res. 2019, 311:337-349. 10.1007\/s00403-019-01908-x","journal-title":"Arch Dermatol Res"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21081063","article-title":"Treatment modalities for acne","volume":"21","author":"Fox L","year":"2016","unstructured":"Fox L, Csongradi C, Aucamp M, du Plessis J, Gerber M. Treatment modalities for acne. Molecules. 2016, 21:1063. 10.3390\/molecules21081063","journal-title":"Molecules"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_41_17","article-title":"Synchronizing pharmacotherapy in acne with review of clinical care","volume":"62","author":"Sacchidanand SA","year":"2017","unstructured":"Sacchidanand SA, Lahiri K, Godse K, et al.. Synchronizing pharmacotherapy in acne with review of clinical care. Indian J Dermatol. 2017, 62:341-357. 10.4103\/ijd.IJD_41_17","journal-title":"Indian J Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03933.x","article-title":"Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission","volume":"25","author":"Borghi A","year":"2011","unstructured":"Borghi A, Mantovani L, Minghetti S, Giari S, Virgili A, Bettoli V. Low-cumulative dose isotretinoin treatment in mild-to-moderate acne: efficacy in achieving stable remission. J Eur Acad Dermatol Venereol. 2011, 25:1094-1098. 10.1111\/j.1468-3083.2010.03933.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5178.190505","article-title":"A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris","volume":"7","author":"Dhaked DR","year":"2016","unstructured":"Dhaked DR, Meena RS, Maheshwari A, Agarwal US, Purohit S. A randomized comparative trial of two low-dose oral isotretinoin regimens in moderate to severe acne vulgaris. Indian Dermatol Online J. 2016, 7:378-385. 10.4103\/2229-5178.190505","journal-title":"Indian Dermatol Online J"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1638","article-title":"Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin","volume":"93","author":"Marron SE","year":"2013","unstructured":"Marron SE, Tomas-Aragones L, Boira S. Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin. Acta Derm Venereol. 2013, 93:701-706. 10.2340\/00015555-1638","journal-title":"Acta Derm Venereol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.2165\/11532280-000000000-00000","article-title":"Therapeutic considerations for severe nodular acne","volume":"12","author":"Newman MD","year":"2011","unstructured":"Newman MD, Bowe WP, Heughebaert C, Shalita AR. Therapeutic considerations for severe nodular acne. Am J Clin Dermatol. 2011, 12:7-14. 10.2165\/11532280-000000000-00000","journal-title":"Am J Clin Dermatol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1159\/000017848","article-title":"Oral retinoids in the treatment of seborrhoea and acne","volume":"196","author":"Orfanos CE","year":"1998","unstructured":"Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998, 196:140-147. 10.1159\/000017848","journal-title":"Dermatology"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12285651","article-title":"Oral isotretinoin (13-cis-retinoic acid) therapy in severe acne: drug and vitamin A concentrations in serum and skin","volume":"86","author":"Rollman O","year":"1986","unstructured":"Rollman O, Vahlquist A. Oral isotretinoin (13-cis-retinoic acid) therapy in severe acne: drug and vitamin A concentrations in serum and skin. J Invest Dermatol. 1986, 86:384-389. 10.1111\/1523-1747.ep12285651","journal-title":"J Invest Dermatol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1159\/000246012","article-title":"Does oral isotretinoin prevent Propionibacterium acnes resistance?","volume":"195","author":"Coates P","year":"1997","unstructured":"Coates P, Adams CA, Cunliffe WJ, et al.. Does oral isotretinoin prevent Propionibacterium acnes resistance?. Dermatology. 1997, 195:4-9. 10.1159\/000246012","journal-title":"Dermatology"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06897.x","article-title":"Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne","volume":"153","author":"Coates P","year":"2005","unstructured":"Coates P, Vyakrnam S, Ravenscroft JC, et al.. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne. Br J Dermatol. 2005, 153:1126-1136. 10.1111\/j.1365-2133.2005.06897.x","journal-title":"Br J Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1517\/eods.3.2.119.27340","article-title":"Safety and side effects of the acne drug, oral isotretinoin","volume":"3","author":"Charakida A","year":"2004","unstructured":"Charakida A, Mouser P, Chu A. Safety and side effects of the acne drug, oral isotretinoin. Expert Opin Drug Saf. 2004, 3:119-129. 10.1517\/eods.3.2.119.27340","journal-title":"Expert Opin Drug Saf"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.08.003","article-title":"Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)\/American Academy of Dermatology Association \"Administrative Regulations for Evidence-Based Clinical Practice Guidelines\"","volume":"50","author":"Hanifin JM","year":"2004","unstructured":"Hanifin JM, Cooper KD, Ho VC, et al.. Guidelines of care for atopic dermatitis, developed in accordance with the American Academy of Dermatology (AAD)\/American Academy of Dermatology Association \"Administrative Regulations for Evidence-Based Clinical Practice Guidelines\". J Am Acad Dermatol. 2004, 50:391-404. 10.1016\/j.jaad.2003.08.003","journal-title":"J Am Acad Dermatol"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.5935\/scd1984-8773.201682814","article-title":"Treatment of moderate to severe acne vulgaris with an oral isotretinoin similar to the reference product","volume":"8","author":"Picosse FR","year":"2016","unstructured":"Picosse FR, Bonatto DC, Hassun KM, Filho ST, Azulay DR, Bagatin E. Treatment of moderate to severe acne vulgaris with an oral isotretinoin similar to the reference product. Surg Cosmet Dermatol. 2016, 8:121-127. 10.5935\/scd1984-8773.201682814","journal-title":"Surg Cosmet Dermatol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.09.001","article-title":"Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology","volume":"95","author":"Bagatin E","year":"2020","unstructured":"Bagatin E, Costa CS, Rocha MA, et al.. Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology. An Bras Dermatol. 2020, 95:19-38. 10.1016\/j.abd.2020.09.001","journal-title":"An Bras Dermatol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.86482","article-title":"Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial","volume":"77","author":"Agarwal US","year":"2011","unstructured":"Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vulgaris: a randomized comparative trial. Indian J Dermatol Venereol Leprol. 2011, 77:688-694. 10.4103\/0378-6323.86482","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.02022.x","article-title":"The familial risk of acne vulgaris in Chinese Hans - a case-control study","volume":"21","author":"Xu SX","year":"2007","unstructured":"Xu SX, Wang HL, Fan X, et al.. The familial risk of acne vulgaris in Chinese Hans - a case-control study. J Eur Acad Dermatol Venereol. 2007, 21:602-605. 10.1111\/j.1468-3083.2006.02022.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1159\/000067819","article-title":"Acne in infancy and acne genetics","volume":"206","author":"Herane MI","year":"2003","unstructured":"Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology. 2003, 206:24-28. 10.1159\/000067819","journal-title":"Dermatology"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2012.07.001","article-title":"Tumor necrosis factor-\u03b1 -308 G\/A and interleukin 10 -1082 A\/G gene polymorphisms in patients with acne vulgaris","volume":"68","author":"Al-Shobaili HA","year":"2012","unstructured":"Al-Shobaili HA, Salem TA, Alzolibani AA, Robaee AA, Settin AA. Tumor necrosis factor-\u03b1 -308 G\/A and interleukin 10 -1082 A\/G gene polymorphisms in patients with acne vulgaris. J Dermatol Sci. 2012, 68:52-55. 10.1016\/j.jdermsci.2012.07.001","journal-title":"J Dermatol Sci"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0871-0","article-title":"Association between tumor necrosis factor-alpha gene promoter polymorphism at position -308 and acne in Turkish patients","volume":"300","author":"Baz K","year":"2008","unstructured":"Baz K, Emin Erdal M, Yazici AC, S\u00f6ylemez F, G\u00fcven\u00e7 U, Ta\u015fdelen B, Ikizo\u011flu G. Association between tumor necrosis factor-alpha gene promoter polymorphism at position -308 and acne in Turkish patients. Arch Dermatol Res. 2008, 300:371-376. 10.1007\/s00403-008-0871-0","journal-title":"Arch Dermatol Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1159\/000319851","article-title":"Association study of tumor necrosis factor receptor type 2 M196R and toll-like receptor 2 Arg753Gln polymorphisms with acne vulgaris in a Chinese Han ethnic group","volume":"221","author":"Tian LM","year":"2010","unstructured":"Tian LM, Xie HF, Yang T, Hu YH, Li J, Wang WZ. Association study of tumor necrosis factor receptor type 2 M196R and toll-like receptor 2 Arg753Gln polymorphisms with acne vulgaris in a Chinese Han ethnic group. Dermatology. 2010, 221:276-284. 10.1159\/000319851","journal-title":"Dermatology"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2010.01530.x","article-title":"Interleukin-1A +4845(G> T) polymorphism is a factor predisposing to acne vulgaris","volume":"76","author":"Szab\u00f3 K","year":"2010","unstructured":"Szab\u00f3 K, Tax G, Kis K, et al.. Interleukin-1A +4845(G> T) polymorphism is a factor predisposing to acne vulgaris. Tissue Antigens. 2010, 76:411-415. 10.1111\/j.1399-0039.2010.01530.x","journal-title":"Tissue Antigens"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1159\/000017855","article-title":"Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne","volume":"196","author":"Paraskevaidis A","year":"1998","unstructured":"Paraskevaidis A, Drakoulis N, Roots I, Orfanos CE, Zouboulis CC. Polymorphisms in the human cytochrome P-450 1A1 gene (CYP1A1) as a factor for developing acne. Dermatology. 1998, 196:171-175. 10.1159\/000017855","journal-title":"Dermatology"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1159\/000092284","article-title":"The relationship between CYP17 -34T\/C polymorphism and acne in Chinese subjects revealed by sequencing","volume":"212","author":"He L","year":"2006","unstructured":"He L, Yang Z, Yu H, Cheng B, Tang W, Dong Y, Xiao C. The relationship between CYP17 -34T\/C polymorphism and acne in Chinese subjects revealed by sequencing. Dermatology. 2006, 212:338-342. 10.1159\/000092284","journal-title":"Dermatology"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.3811205.x","article-title":"Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne","volume":"48","author":"Ostlere LS","year":"1998","unstructured":"Ostlere LS, Rumsby G, Holownia P, Jacobs HS, Rustin MH, Honour JW. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne. Clin Endocrinol (Oxf). 1998, 48:209-215. 10.1046\/j.1365-2265.1998.3811205.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1159\/000202983","article-title":"Relationship between the CAG repeat polymorphism in the androgen receptor gene and acne in the Han ethnic group","volume":"218","author":"Yang Z","year":"2009","unstructured":"Yang Z, Yu H, Cheng B, Tang W, Dong Y, Xiao C, He L. Relationship between the CAG repeat polymorphism in the androgen receptor gene and acne in the Han ethnic group. Dermatology. 2009, 218:302-306. 10.1159\/000202983","journal-title":"Dermatology"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3870","article-title":"Two new susceptibility loci 1q24.2 and 11p11.2 confer risk to severe acne","volume":"5","author":"He L","year":"2014","unstructured":"He L, Wu WJ, Yang JK, et al.. Two new susceptibility loci 1q24.2 and 11p11.2 confer risk to severe acne. Nat Commun. 2014, 5:2870. 10.1038\/ncomms3870","journal-title":"Nat Commun"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5020","article-title":"Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris","volume":"5","author":"Navarini AA","year":"2014","unstructured":"Navarini AA, Simpson MA, Weale M, et al.. Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris. Nat Commun. 2014, 5:4020. 10.1038\/ncomms5020","journal-title":"Nat Commun"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1654075","article-title":"Acne vulgaris: new evidence in pathogenesis and future modalities of treatment","volume":"32","author":"Hazarika N","year":"2021","unstructured":"Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2021, 32:277-285. 10.1080\/09546634.2019.1654075","journal-title":"J Dermatolog Treat"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.17633","article-title":"Management of acne vulgaris: a review","volume":"326","author":"Eichenfield DZ","year":"2021","unstructured":"Eichenfield DZ, Sprague J, Eichenfield LF. Management of acne vulgaris: a review. JAMA. 2021, 326:2055-2067. 10.1001\/jama.2021.17633","journal-title":"JAMA"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12876053","article-title":"Cytokine modulation of keratinocyte cytokines","volume":"94","author":"Ansel J","year":"1990","unstructured":"Ansel J, Perry P, Brown J, et al.. Cytokine modulation of keratinocyte cytokines. J Invest Dermatol. 1990, 94:101S-107S. 10.1111\/1523-1747.ep12876053","journal-title":"J Invest Dermatol"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12874944","article-title":"Evidence for an epidermal cytokine network","volume":"95","author":"Luger TA","year":"1990","unstructured":"Luger TA, Schwarz T. Evidence for an epidermal cytokine network. J Invest Dermatol. 1990, 95:100S-104S. 10.1111\/1523-1747.ep12874944","journal-title":"J Invest Dermatol"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.6.1609","article-title":"Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light","volume":"172","author":"K\u00f6ck A","year":"1990","unstructured":"K\u00f6ck A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med. 1990, 172:1609-1614. 10.1084\/jem.172.6.1609","journal-title":"J Exp Med"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12876130","article-title":"The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses","volume":"94","author":"Kupper TS","year":"1990","unstructured":"Kupper TS. The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol. 1990, 94:146S-150S. 10.1111\/1523-1747.ep12876130","journal-title":"J Invest Dermatol"},{"key":"ref78","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(17)41895-3","article-title":"Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation","volume":"269","author":"Miller CC","year":"1994","unstructured":"Miller CC, Hale P, Pentland AP. Ultraviolet B injury increases prostaglandin synthesis through a tyrosine kinase-dependent pathway. Evidence for UVB-induced epidermal growth factor receptor activation. J Biol Chem. 1994, 269:3529-3533.","journal-title":"J Biol Chem"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.3.1535","article-title":"Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses","volume":"169","author":"Kim J","year":"2002","unstructured":"Kim J, Ochoa MT, Krutzik SR, et al.. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002, 169:1535-1541. 10.4049\/jimmunol.169.3.1535","journal-title":"J Immunol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12371738","article-title":"Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67","volume":"102","author":"Knaggs HE","year":"1994","unstructured":"Knaggs HE, Holland DB, Morris C, Wood EJ, Cunliffe WJ. Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Invest Dermatol. 1994, 102:89-92. 10.1111\/1523-1747.ep12371738","journal-title":"J Invest Dermatol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/BF00595286","article-title":"Cellular dynamics of comedo formation in acne vulgaris","volume":"242","author":"Plewig G","year":"1971","unstructured":"Plewig G, Fulton JE, Kligman AM. Cellular dynamics of comedo formation in acne vulgaris. Arch Dermatol Forsch. 1971, 242:12-29. 10.1007\/BF00595286","journal-title":"Arch Dermatol Forsch"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.10.3758","article-title":"Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation","volume":"87","author":"Pietenpol JA","year":"1990","unstructured":"Pietenpol JA, Holt JT, Stein RW, Moses HL. Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci U S A. 1990, 87:3758-3762. 10.1073\/pnas.87.10.3758","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E10-11-0879","article-title":"A decisive function of transforming growth factor-\u03b2\/Smad signaling in tissue morphogenesis and differentiation of human HaCaT keratinocytes","volume":"22","author":"Buschke S","year":"2011","unstructured":"Buschke S, Stark HJ, Cerezo A, et al.. A decisive function of transforming growth factor-\u03b2\/Smad signaling in tissue morphogenesis and differentiation of human HaCaT keratinocytes. Mol Biol Cell. 2011, 22:782-794. 10.1091\/mbc.E10-11-0879","journal-title":"Mol Biol Cell"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-13-2","article-title":"TGF\u03b2 signaling regulates lipogenesis in human sebaceous glands cells","volume":"13","author":"McNairn AJ","year":"2013","unstructured":"McNairn AJ, Doucet Y, Demaude J, et al.. TGF\u03b2 signaling regulates lipogenesis in human sebaceous glands cells. BMC Dermatol. 2013, 13:2. 10.1186\/1471-5945-13-2","journal-title":"BMC Dermatol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12317162","article-title":"Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin","volume":"105","author":"Thiboutot D","year":"1995","unstructured":"Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Invest Dermatol. 1995, 105:209-214. 10.1111\/1523-1747.ep12317162","journal-title":"J Invest Dermatol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/j.0906-6705.2005.0285a.x","article-title":"What is the pathogenesis of acne?","volume":"14","author":"Zouboulis C","year":"2005","unstructured":"Zouboulis C, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, Rosenfield R. What is the pathogenesis of acne?. Exp Dermatol. 2005, 14:143. 10.1111\/j.0906-6705.2005.0285a.x","journal-title":"Exp Dermatol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.438","article-title":"IL-1\u03b2 drives inflammatory responses to propionibacterium acnes in vitro and in vivo","volume":"134","author":"Kistowska M","year":"2014","unstructured":"Kistowska M, Gehrke S, Jankovic D, et al.. IL-1\u03b2 drives inflammatory responses to propionibacterium acnes in vitro and in vivo. J Invest Dermatol. 2014, 134:677-685. 10.1038\/jid.2013.438","journal-title":"J Invest Dermatol"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2009.04.008","article-title":"Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity","volume":"9","author":"Sanjabi S","year":"2009","unstructured":"Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol. 2009, 9:447-453. 10.1016\/j.coph.2009.04.008","journal-title":"Curr Opin Pharmacol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.06.012","article-title":"Advances in keratinocyte delivery in burn wound care","volume":"123","author":"Ter Horst B","year":"2018","unstructured":"Ter Horst B, Chouhan G, Moiemen NS, Grover LM. Advances in keratinocyte delivery in burn wound care. Adv Drug Deliv Rev. 2018, 123:18-32. 10.1016\/j.addr.2017.06.012","journal-title":"Adv Drug Deliv Rev"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2009.2","article-title":"Skin substitutes: a brief review of types and clinical applications","volume":"24","author":"Alrubaiy L","year":"2009","unstructured":"Alrubaiy L, Al-Rubaiy KK. Skin substitutes: a brief review of types and clinical applications. Oman Med J. 2009, 24:4-6. 10.5001\/omj.2009.2","journal-title":"Oman Med J"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3390\/jfb6030547","article-title":"Advances in skin substitutes-potential of tissue engineered skin for facilitating anti-fibrotic healing","volume":"6","author":"Varkey M","year":"2015","unstructured":"Varkey M, Ding J, Tredget EE. Advances in skin substitutes-potential of tissue engineered skin for facilitating anti-fibrotic healing. J Funct Biomater. 2015, 6:547-563. 10.3390\/jfb6030547","journal-title":"J Funct Biomater"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1998.tb02509.x","article-title":"The use of Apligraf in acute wounds","volume":"25","author":"Kirsner RS","year":"1998","unstructured":"Kirsner RS. The use of Apligraf in acute wounds. J Dermatol. 1998, 25:805-811. 10.1111\/j.1346-8138.1998.tb02509.x","journal-title":"J Dermatol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1097\/01.prs.0000222534.79915.d3","article-title":"The efficacy of Apligraf in the treatment of diabetic foot ulcers","volume":"117","author":"Dinh TL","year":"2006","unstructured":"Dinh TL, Veves A. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg. 2006, 117:152S-157S. 10.1097\/01.prs.0000222534.79915.d3","journal-title":"Plast Reconstr Surg"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16226","article-title":"Apligraf as an alternative to skin grafting in the pediatric population","volume":"13","author":"Eudy M","year":"2021","unstructured":"Eudy M, Eudy CL, Roy S. Apligraf as an alternative to skin grafting in the pediatric population. Cureus. 2021, 13:e16226. 10.7759\/cureus.16226","journal-title":"Cureus"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1998.tb02510.x","article-title":"Apligraf treatment of venous ulcers and other chronic wounds","volume":"25","author":"Falanga V","year":"1998","unstructured":"Falanga V. Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol. 1998, 25:812-817. 10.1111\/j.1346-8138.1998.tb02510.x","journal-title":"J Dermatol"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2008.00512.x","article-title":"A novel model of wound healing in the SCID mouse using a cultured human skin substitute","volume":"50","author":"Windsor ML","year":"2009","unstructured":"Windsor ML, Eisenberg M, Gordon-Thomson C, Moore GP. A novel model of wound healing in the SCID mouse using a cultured human skin substitute. Australas J Dermatol. 2009, 50:29-35. 10.1111\/j.1440-0960.2008.00512.x","journal-title":"Australas J Dermatol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/s0305-4179(03)00164-5","article-title":"The use of a collagen sponge\/living cell composite material to treat donor sites in burn patients","volume":"29","author":"Still J","year":"2003","unstructured":"Still J, Glat P, Silverstein P, Griswold J, Mozingo D. The use of a collagen sponge\/living cell composite material to treat donor sites in burn patients. Burns. 2003, 29:837-841. 10.1016\/s0305-4179(03)00164-5","journal-title":"Burns"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/142699-role-of-oral-retinoids-in-treatment-of-acne-vulgaris-with-a-bioinformatics-based-perspective-of-personalized-medicine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T15:00:03Z","timestamp":1707490803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/142699-role-of-oral-retinoids-in-treatment-of-acne-vulgaris-with-a-bioinformatics-based-perspective-of-personalized-medicine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,23]]},"references-count":97,"URL":"https:\/\/doi.org\/10.7759\/cureus.38019","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,23]]}}}